Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Charles River Labs ( (CRL) ) is now available.
At its annual meeting of shareholders held on May 5, 2026, Charles River Laboratories International, Inc. secured approval for its 2026 Long-Term Incentive Plan, which had been adopted by the board in March pending shareholder consent. The plan is intended to guide future equity-based compensation and was outlined in the company’s March 31, 2026 proxy filing.
Shareholders also elected 12 directors to serve until the 2027 annual meeting, endorsed on an advisory basis the compensation of named executive officers, and ratified PricewaterhouseCoopers LLP as independent auditor for fiscal 2026. The voting, tabulated by Computershare Trust Company, N.A., reflected broad support for the board’s proposals, reinforcing the company’s governance structure and executive incentive framework.
The most recent analyst rating on (CRL) stock is a Buy with a $235.00 price target. To see the full list of analyst forecasts on Charles River Labs stock, see the CRL Stock Forecast page.
Spark’s Take on CRL Stock
According to Spark, TipRanks’ AI Analyst, CRL is a Neutral.
Overall score reflects solid cash generation and a reaffirmed plan for margin expansion and EPS growth, tempered by current net losses and compressed profitability alongside moderate-to-elevated leverage. Technicals are modestly supportive, while valuation remains pressured due to the negative P/E.
To see Spark’s full report on CRL stock, click here.
More about Charles River Labs
Charles River Laboratories International, Inc. operates in the life sciences and pharmaceutical services industry, providing preclinical and clinical laboratory services that support drug discovery and development. The company focuses on partnering with biopharmaceutical and biotechnology clients to advance research pipelines and bring new therapies to market.
Average Trading Volume: 1,009,931
Technical Sentiment Signal: Hold
Current Market Cap: $8.56B
Find detailed analytics on CRL stock on TipRanks’ Stock Analysis page.